Immunobiology of the Peripheral Nervous System

  • Richard A. C. Hughes
Part of the Clinical Medicine and the Nervous System book series (CLIN.MED.NERV.)

Abstract

Peripheral nerves have unique properties which govern the outcome of inflammatory and immunological disorders affecting them. Nerve cells are in danger of being affected by inflammatory disorders anywhere along their extremely lengthy processes. Some motor neurons and dorsal root ganglion cell axons are more than a metre long. Fortunately the axons are wrapped and protected by myelin or Schwann cell cytoplasm. The integrity of the nerve terminals depends on uninterrupted axonal transport which occurs both at slow and fast (over 400 mm/day) rates. RNA is transcribed and protein and membrane materials are synthesised in the cell body and then transported down the axons. However, the traffic is two-way and for instance IgG (Fabian and Petroff 1987) and viruses, including rabies virus, may be carried from the periphery to the central nervous system via a retrograde axonal transport system. Inflammatory disorders have a particular tendency to affect the proximal ventral and dorsal roots. Vulnerable sites are the spinal cord entry zones, the dorsal root ganglia, and the junction of the ventral and dorsal roots where they become tightly invested by collagenous tissue. This junction is a point at which the nerve fibres might be expected to be particularly prone to compression by an oedematous inflammatory process.

Keywords

Interferon Histamine Doxorubicin Compaction Peri 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baba H, Daune GC, Ilyas AA et al. (1989) Anti GM1 ganglioside antibodies with differing fine specificities in patients with multifocal motor neuropathy. J Neuroimmunol 25: 143–150PubMedCrossRefGoogle Scholar
  2. Beuche W, Friede RL (1984) The role of non-resident cells in Wallerian degeneration. J Neurocytol 13: 767–796PubMedCrossRefGoogle Scholar
  3. Brosnan CF, Stoner GL, Bloom BR, Wisniewski HM (1977) Studies in demyelination by activated lymphocytes in the rabbit eye. J Immunol 118: 2103–2110PubMedGoogle Scholar
  4. Brosnan CF, Selmaj K, Raine CS (1988) Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J Neuroimmunol 18: 87–94PubMedCrossRefGoogle Scholar
  5. Brostoff SW (1984) Antigens of peripheral nervous system myelin. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R (eds) Peripheral neuropathy. WB Saunders, Philadelphia, pp 562–576Google Scholar
  6. Carroll WM, Jennings AR, Mastaglia FL (1984) Experimental demyelinating optic neuropathy induced by intra-neural injection of galactocerebroside antiserum. J Neurol Sci 85: 125–135CrossRefGoogle Scholar
  7. Deibler GE, Driscoll BF, Kies MW (1978) Immunochemical and biochemical studies demonstrating the identity of a bovine spinal cord protein (SCP) and a basic protein of bovine peripheral nerve myelin ( BF ). J Neurochem 30: 401–412PubMedCrossRefGoogle Scholar
  8. Fabian RH, Petroff G (1987) Intraneuronal IgG in the central nervous system: uptake by retrograde axonal transport. Neurology 37: 1780–1784PubMedGoogle Scholar
  9. Goban Y, Saida T, Saida K, Nishitkani H, Kameyana M (1986) Role of non-specific myelin destruction by delayed type hypersensitivity in primary demyelination. J Neurol Sci 74: 97–109PubMedCrossRefGoogle Scholar
  10. Gregson NA, Leibowitz S (1985) IgM paraproteinaemia, polyneuropathy and MAG. Neuropathol Appl Neurobiol 11: 329–347PubMedCrossRefGoogle Scholar
  11. Gregson NA, Kennedy MC, Leibowitz S (1971) Immunological reactions with lysolecithinsolubilised myelin. Immunology 20: 501–512PubMedGoogle Scholar
  12. Hall SM, Gregson NA (1971) The in vivo and ultrastructural effects of injection of lysophosphatidyl choline into myelinated peripheral nerve fibres. J Cell Sci 9: 769–789PubMedGoogle Scholar
  13. Hays AP, Latov N, Takatsu M, Sherman WH (1987) Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti MAG M protein. Neurology 37: 242–246PubMedGoogle Scholar
  14. Hughes RAC, Powell HC (1984) Experimental allergic neuritis: demyelination induced by P2 alone and non-specific enhancement by cerebroside. J Neuropathol Exp Neurol 43: 154–161PubMedCrossRefGoogle Scholar
  15. Hughes RAC, Powell HC, Braheny SL, Brostoff SW (1985) Endoneurial injection of antisera to myelin antigens. Muscle Nerve 8: 516–522PubMedCrossRefGoogle Scholar
  16. Hughes RAC, Atkinson PF, Gray IA, Taylor WA (1987) Major histocompatibility antigens and lymphocyte subsets during experimental allergic neuritis in the Lewis rat. J Neurol 234: 390–395PubMedCrossRefGoogle Scholar
  17. Izumo S, Linington C, Wekerle H, Meyermann R (1985) Morphological study on EAN mediated by T-cell line specific for bovine P2 protein in Lewis rats. Lab Invest 53: 209–218PubMedGoogle Scholar
  18. Jacobs JM, MacFarlane RM, Cavanagh JB (1976) Vascular leakage in the dorsal root ganglia of the rat, studied with horseradish peroxidase. J Neurol Sci 29: 95–107PubMedCrossRefGoogle Scholar
  19. Jones TA, Bergfors T, Sedzik J, Unge T (1988) The three-dimensional structure of P2 myelin protein. EMBO 7: 1597–1604Google Scholar
  20. Kadlubowski M, Hughes RAC, Gregson NA (1984) Spontaneous and experimental neuritis and the distribution of the myelin protein P2 in the nervous system. J Neurochem 42: 123–129PubMedCrossRefGoogle Scholar
  21. Koski CL, Vanguri P, Shin ML (1985) Activation of the alternative pathway of complement by human peripheral nerve myelin. J Immunol 134: 1810–1814PubMedGoogle Scholar
  22. Lassmann H, Brunner C, Bradl M, Linington C (1988) Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines the size and structure of demyelinated lesions. Acta Neuropathol 75: 566–576PubMedCrossRefGoogle Scholar
  23. Linington C, Izumo S, Suzuki M, Uyemura M, Meyermann R, Wekerle H (1984) A permanent rat T cell line that mediates experimental allergic neuritis in the rat in vitro. J Immunol 133: 1946–1950PubMedGoogle Scholar
  24. Linington C, Bradl M, Lassmann H, Brunner C, Vass K (1988) Augmentation of demyelination in rats: acute allergic encephalomyelitis directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 130: 443–454PubMedGoogle Scholar
  25. Low PA (1984) Endoneurial fluid pressure and microenvironment of the nerve, In: Dyck PJ, Thomas PK, Lambert EH, Bunge R (eds) Peripheral neuropathy. WB Saunders, Philadelphia, pp 599–617Google Scholar
  26. Marcus DM, Latov N, Hsi BP, Gillard BK (1989) Measurement and significance of antibodies against GM1 ganglioside. Report of a Workshop, 18 April 1989, Chicago, IL, USA. J Neuroimmunol 25: 255–259PubMedCrossRefGoogle Scholar
  27. Milner P, Lovelidge CA, Taylor WA, Hughes RAC (1987) Po myelin protein produces experimental allergic neuritis in Lewis rats. J Neurol Sci 79: 275–285PubMedCrossRefGoogle Scholar
  28. Mizisin AP, Wiley CA, Hughes RAC, Powell HC (1987) Peripheral nerve demyelination in rabbits after inoculation with Freund’s complete adjuvant alone or in combination with lipid hapten. J Neuroimmunol 16: 381–395PubMedCrossRefGoogle Scholar
  29. Myers RR, Powell HC, Heckman HM, Costello ML, Katz J (1981) Biophysical and pathological effects of cryogenic nerve lesion. Ann Neurol 10: 478–485PubMedCrossRefGoogle Scholar
  30. Nagai Y, Momoi T, Saito M, Mitsuzawa E, Ohtani S (1976) Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides. Neurosci Lett 2: 107–111PubMedCrossRefGoogle Scholar
  31. Norton WT, Cammer W (1984) Isolation and characterisation of myelin. In: Morell P (ed) Myelin, 2nd edn. Plenum Press, New YorkGoogle Scholar
  32. Norton WT (1985) Recent advances in myelin biochemistry. Ann NY Acad Sci 436: 5–10CrossRefGoogle Scholar
  33. Olsson Y (1984) Vascular permeability in the peripheral nervous system. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R (eds) Peripheral neuropathy. WB Saunders, Philadelphia, pp 579–597Google Scholar
  34. Perlmann P, Perlmann H, Muller-Eberhard HJ (1975) Cytolytic lymphocytic cells with complement receptor in human blood. Induction of cytolysis by Igh antibody but not by target cell-bound C3.J Exp Med 141: 287–296Google Scholar
  35. Powell HC, Hughes RAC (1987) Role of non-specific myelin destruction by delayed type hypersensitivity in primary demyelination. J Neurol Sci 74: 97Google Scholar
  36. Powell HC, Myers RR, Costello ML, Lampert PW (1979) Endoneural fluid pressure in Wallerian degeneration. Ann Neurol 5: 550–573PubMedCrossRefGoogle Scholar
  37. Powell HC, Myers RR, Costello ML (1980) Increased endoneurial fluid pressure following injection of histamine and compound 48/80 into rat peripheral nerves. Lab Invest 43: 564–573PubMedGoogle Scholar
  38. Powell HC, Braheny SL, Hughes RAC, Lampert PW (1984) Antigen-specific demyelination and significance of the bystander effect in peripheral nerves. Am J Pathol 114: 443–453PubMedGoogle Scholar
  39. Quarles RH (1984) Myelin-associated glycoprotein in development and disease. Dev Neurosci 6: 285–303CrossRefGoogle Scholar
  40. Quarles RH, Ilyas AA, Willison HJ (1986) Antibodies to glycolipids in demyelinating diseases of the human peripheral nervous system. Chem Phys Lipids 42: 235–248PubMedCrossRefGoogle Scholar
  41. Raine CS, Bornstein MB (1979) Experimental allergic neuritis — ultrastructure of serum induced myelin aberrations in peripheral nervous system cultures. Lab Invest 40:423–432PubMedGoogle Scholar
  42. Raine CS, Johnson AB, Marcus DM, Suzuki A, Bornstein MB (1981) Demyelination in vitro — absorption studies demonstrate that galactocerebroside is a major target. J Neurol Sci 52: 117–131PubMedCrossRefGoogle Scholar
  43. Rostami A, Brown MJ, Lisak RP, Sumner AJ, Zweiman B, Pleasure DE (1984) The role of myelin 112 protein in the production of experimental allergic neuritis. Ann Neurol 16: 680–685PubMedCrossRefGoogle Scholar
  44. Saida T, Saida K, Dorfman SH (1979) Experimental allergic neuritis induced by sensitisation with galactocerebroside. Science 204: 1103–1106PubMedCrossRefGoogle Scholar
  45. Saida T, Saida K, Silberberg DH, Brown MK (1981) Experimental allergic neuritis induced by galactocerebroside. Ann Neurol 9 supp1: 87–101Google Scholar
  46. Saida T, Saida K, Olawa K, Goban Y, Kawanishi T (1987) Experimental models of immune-mediated demyelination in peripheral nerve. In: Aarli JA, Behan WMH, Behan PO (eds) Clinical Neuroimmunology. Blackwell Scientific Publications, Oxford, pp 102–113Google Scholar
  47. Schwartz M, Sela BA, Eshhar N (1982) Antibodies to gangliosides and myelin autoantigens are produced in mice following sciatic nerve injury. J Neurochem 38: 1192–1195PubMedCrossRefGoogle Scholar
  48. Seil FJ (1977) Tissue culture studies of demyelinating disease: a critical review. Ann Neurol 2: 345–355PubMedCrossRefGoogle Scholar
  49. Seil FJ, Kies MW, Bacon ML (1981) A comparison of demyelinating and myelination inhibiting factor induction by whole peripheral nerve tissue and P2 protein. Brain Res 210: 441–448PubMedCrossRefGoogle Scholar
  50. Sergott RC, Brown MJ, Silberberg DH, Lisak RP (1984) Antigalactocerebroside serum demye-linates optic nerve in vitro. J Neurol Sci 64: 297–303PubMedCrossRefGoogle Scholar
  51. Smith KJ, Hall SM (1988) Peripheral demyelination and remyelination initiated by the calcium-selective ionophore ionomycin: in vivo observations. J Neurol Sci 83: 37–53PubMedCrossRefGoogle Scholar
  52. Stoner GL, Brosnan CF, Wisniewski HM, Bloom BR (1977) Studies on demyelination by activated lymphocytes in the rabbit eye. Effects of a monuclear cell infiltrate induced by products of activated lymphocytes. J Immunol 118: 2094–2102PubMedGoogle Scholar
  53. Thomas PK, Olsson Y (1984) Microscopic anatomy and function of the connective tissue components of peripheral nerve. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R (eds) Peripheral neuropathy. WB Saunders, Philadelphia, pp 97–120Google Scholar
  54. Vedeler CA (1987) Demonstration of Fc gamma receptors on human peripheral nerve fibres. J Neuroimmunol 15: 207–216PubMedCrossRefGoogle Scholar
  55. Ward RHR, Lachmann PJ (1985) Monoclonal antibodies which react with lymphocyte-lysed target cells and which cross-react with complement-lysed ghosts. Immunology 56: 179–188PubMedGoogle Scholar
  56. Wekerle H, Linington C, Lassmann H, Meyermann R (1986a) Cellular immune reactivity within the CNS. Trends in Neurol Sci 9: 271–277CrossRefGoogle Scholar
  57. Wekerle H, Schwab M, Linington C, Meyermann R (1986b) Antigen presentation in the peripheral nervous system: Schwann cells present endogenous myelin autoantigens to lymphocytes. Eur J Immunol 16: 1551–1557PubMedCrossRefGoogle Scholar
  58. Westland K, Pollard JD (1987) Proteinase induced demyelination. An electrophysiological and histological study. J Neurol Sci 82: 41–53PubMedCrossRefGoogle Scholar
  59. Wisniewski HM, Bloom BR (1975) Primary demyelination as a non-specific consequence of circulating immunocytes in Guillan—Barré syndrome. A cell-mediated immune reaction. J Exp Med 141: 346–359PubMedCrossRefGoogle Scholar
  60. Yonezawa T, Hasegawa M, Arizona N, Okabe H (1981) Antigenicity of galactocerebroside in experimental allergic demyelinating diseases. Acta Neuropathol suppl. 7: 162–164PubMedGoogle Scholar
  61. Young JD-E, Liu C-C (1988) Multiple mechanisms of lymphocyte-mediated toxicity. Immunol Today 9: 140–144PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 1990

Authors and Affiliations

  • Richard A. C. Hughes
    • 1
  1. 1.Department of Neurology, United Medical and Dental Schools of Guy’s and St Thomas’s HospitalsGuy’s HospitalLondonUK

Personalised recommendations